Aspo Plc
28.1.2026 17:30:00 CET | Globenewswire | Press release
Aspo Plc: Share repurchase 28.1.2026
Aspo Plc: Share repurchase 28.1.2026
| Aspo Plc | ANNOUNCEMENT | 28.1.2026 |
| Aspo Plc: Share repurchase 28.1.2026 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 28.1.2026 | |
| Bourse trade | Buy | |
| Share | ASPO | |
| Amount | 2 716 | Shares |
| Average price/ share | 7,8347 | EUR |
| Total cost | 21 279,05 | EUR |
| Aspo Plc now holds a total of 132 268 shares | ||
| including the shares repurchased on 28.1.2026 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Aspo Plc | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
| For more information, please contact: | ||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | ||
| www.aspo.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
Zealand Pharma24.8.2026 17:05:00 CEST | Press release
Zealand Pharma – Notification of holding of treasury shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom